Open pelvic lymph node dissection for prostate cancer: a reassessment.

[1]  E. Klein,et al.  Early hospital discharge after radical retropubic prostatectomy: impact on cost and complication rate. , 1994, Urology.

[2]  P. Narayan,et al.  Utility of preoperative serumprostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer , 1994 .

[3]  D. Bostwick,et al.  Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. , 1994, The Journal of urology.

[4]  D. Haraf,et al.  Laparoscopic pelvic lymph node dissection: a review of 103 consecutive cases. , 1994, The Journal of urology.

[5]  D. Chan,et al.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.

[6]  R. B. Smith,et al.  The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. , 1993, The Journal of urology.

[7]  J. Oesterling,et al.  Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade. , 1993, Urology.

[8]  L R Kavoussi,et al.  Complications of laparoscopic pelvic lymph node dissection. , 1993, The Journal of urology.

[9]  W. Catalona,et al.  Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. , 1992, The Journal of urology.

[10]  D. Johnson,et al.  Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases. , 1990, Urology.

[11]  G. Williams,et al.  Intraoperative and early complications of staging pelvic lymph node dissection in prostatic adenocarcinoma. , 1990, Urology.

[12]  P. Scardino,et al.  Prognostic significance of lymph nodal metastases in prostate cancer. , 1989, The Journal of urology.

[13]  T. Stamey,et al.  Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. , 1989, The Journal of urology.

[14]  J. W. Segura,et al.  Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy. , 1987, The Journal of urology.

[15]  J. Oesterling,et al.  Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens. , 1986, The Journal of urology.

[16]  S. Loening,et al.  Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate. , 1983, The Journal of urology.

[17]  W. Catalona,et al.  Accuracy of frozen section detection of lymph node metastases in prostatic carcinoma. , 1982, The Journal of urology.

[18]  C. Brendler,et al.  Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. , 1980, The Journal of urology.

[19]  W. Ellis,et al.  Advanced prostatic carcinoma. Early versus late endocrine therapy. , 1991, The Urologic clinics of North America.

[20]  R. Middleton.  Value of and indications for pelvic lymph node dissection in the staging of prostate cancer. , 1988, NCI monographs : a publication of the National Cancer Institute.